Tingting Cui

Tingting Cui is an experienced scientist with a strong background in bioprocess development and chemistry manufacturing control (CMC). From July 2011 to May 2017 at MedImmune, Tingting served as Scientist I and Scientist II, applying statistical approaches in downstream process development and leading investigations on antibody fragmentation. Prior experience includes a role as Senior Purification Development Scientist at Allergan Biologics Ltd., where process development for biotherapeutic molecules was emphasized, and as a Research Scientist at Novozymes focusing on fusion proteins and peptides. As Senior Scientist and subsequently Associate Principal Scientist at AstraZeneca from April 2019 to present, responsibilities included leading nucleic acid process development and overseeing process development teams. Tingting's academic qualifications include an MSc with distinction in Biochemical Engineering from the University of Birmingham and a PhD in Bioprocess Technology from the University of Westminster.